NewellS.GoussevskaiaA.SwanJ.BresnenM.ObembeA. (2008). Interdependencies in complex project ecologies: The case of biomedical innovation. Long Range Plann. 41(1), 33–54.
2.
LeendersM.WierengaB. (2008). The effect of the marketing–R&D interface on new product performance: The critical role of resources and scope. Int. J. Res. Market. 25(1), 56–68.
3.
SmithB. D. (2008). Walking the line. Pharmaceutical Executive Europe, January. PDF available on request from the author at brian.smith@pragmedic.com.
4.
HoekJ. (2008). Ethical and practical implications of pharmaceutical direct-to-consumer advertising. Int. J. Volun. Non-Profit Sector Market. 13(1), 73–87.
5.
GhodeswarB. M.VaidyanathanJ. (2007). Organisational adoption of medical technology in the healthcare sector. J. Serv. Res.7(2), 57–81.
6.
SmithB. D.AwopetuB.PiperK. (2006). Test of strength. Pharmaceutical Marketing Europe. Winter. PDF available on request from the author at brian.smith@pragmedic.com.
